Statements (74)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:film_production_company
|
| gptkbp:challenges |
counterfeit drugs
|
| gptkbp:collaborates_with |
academic institutions
|
| gptkbp:contributed_to |
global economy
|
| gptkbp:develops |
vaccines
|
| https://www.w3.org/2000/01/rdf-schema#label |
Pharmaceutical Industry
|
| gptkbp:includes |
biotechnology companies
generic drug manufacturers research and development organizations |
| gptkbp:investment |
research and development
|
| gptkbp:is_a_source_of |
employment
biopharmaceuticals new therapies medical innovations therapeutic options |
| gptkbp:is_affected_by |
economic factors
technological advancements healthcare policies international trade agreements market competition socioeconomic factors public perception emerging diseases global health crises |
| gptkbp:is_associated_with |
gptkb:municipality
ethical considerations healthcare disparities healthcare reform efforts drug pricing debates |
| gptkbp:is_challenged_by |
regulatory changes
|
| gptkbp:is_characterized_by |
mergers and acquisitions
high profit margins intellectual property issues rapid technological change global collaborations high regulatory barriers |
| gptkbp:is_essential_for |
public health
|
| gptkbp:is_influenced_by |
gptkb:Research_Institute
stakeholder interests patient needs patent laws |
| gptkbp:is_involved_in |
gptkb:Company
patient education regulatory compliance clinical trials drug discovery safety monitoring drug formulation healthcare policy advocacy drug safety assessments patient access programs drug marketing healthcare collaborations |
| gptkbp:is_known_for |
high research costs
long development timelines |
| gptkbp:is_linked_to |
innovation
|
| gptkbp:is_subject_to |
regulatory scrutiny
market access challenges |
| gptkbp:key_people |
disease management
preventive medicine. |
| gptkbp:notable_players |
chronic disease management
healthcare sector |
| gptkbp:notable_recipients |
gptkb:hospital
healthcare advancements |
| gptkbp:operates_in |
global markets
|
| gptkbp:produced_by |
medications
over-the-counter drugs |
| gptkbp:regulates |
government agencies
|
| gptkbp:requires |
clinical research
|
| gptkbp:utilizes |
pharmacovigilance
|
| gptkbp:was_a_factor_in |
healthcare delivery
|
| gptkbp:bfsParent |
gptkb:XMPP_Extension_Protocol
gptkb:robot |
| gptkbp:bfsLayer |
3
|